Axsome Therapeutics Inc (NASDAQ:AXSM)

72.12
Delayed Data
As of Oct 19
 -1.69 / -2.29%
Today’s Change
20.48
Today|||52-Week Range
109.94
-30.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization3.5K20.5K42.6K48.9K
 
 
 
 
 
 
Operating ExpensesGross Income-3.5K-20.5K-42.6K-48.9K
 
 
 
 
 
General Expenses9.2M27.5M27.1M32.8M
 
 
 
 
 
Research And Development6.8M21.2M20.0M23.5M
 
 
 
 
 
Total Operating Expenses9.2M27.5M27.2M32.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.2M-27.5M-27.2M-32.8M
 
 
 
 
 
Extraordinary Credit166.3K0.000.002.8M
 
 
 
Extraordinary Charge-2.4M0.00-646.0K0.00
 
 
 
Interest Expense On Debt0.00132.4K1.3M1.1M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.6M-27.7M-29.2M-31.2M
 
 
 
 
 
Income Taxes0.00-474.3K-207.1K-217.4K
 
 
 
 
Net Income-10.6M-27.2M-28.9M-31.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.9M19.2M22.8M26.9M
 
 
 
 
 
Shares To Calculate EPS Diluted11.9M19.2M22.8M26.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.88-$1.42-$1.27-$1.15
 
 
 
 
 
EPS Diluted-$0.88-$1.42-$1.27-$1.15